Neurobiology · Physiology

Neurotransmitter

Reference entry · last updated September 15, 2026

A neurotransmitter is an endogenous chemical substance synthesized within a neuron, packaged into synaptic vesicles, and exocytosed into the synaptic cleft in response to electrical depolarization to alter the physiological state of an adjacent postsynaptic cell [1, 2].

1. First principles and criteria for identification

Intercellular signaling in nervous systems occurs primarily through chemical synapses. Action potentials conduct along axonal membranes through voltage-gated ion channels as electrical impulses. However, the physical gap of the synaptic cleft (approximately 20 nm) acts as a high-resistance electrical barrier that prevents direct passive electrotonic spread for most central synapses.

Chemical synaptic transmission overcomes this barrier by translating electrical depolarization into the release of diffusible chemical messengers. The existence of chemical transmission was definitively proven in 1921 by Otto Loewi, whose classic dual-perfusion frog heart experiment demonstrated that electrical vagus nerve stimulation releases a diffusible substance (initially called Vagusstoff, later identified as acetylcholine) capable of slowing a second, uninnervated heart [1].

To differentiate authentic neurotransmitters from non-specific metabolites or ambient neuromodulators, neurophysiologists formalize rigorous identification criteria established by Robert Werman and expanded in modern neurobiology [2]:

• Presynaptic Synthesis: The chemical must be synthesized within the presynaptic neuron from precursor molecules via specific metabolic enzymes.
• Storage: The substance must be stored in presynaptic terminals, typically packaged into specialized membrane-bound synaptic vesicles.
• Calcium-Dependent Release: Depolarization of the presynaptic terminal must trigger calcium-dependent exocytosis of the chemical into the synaptic cleft in biologically relevant concentrations.
• Identity of Action: Direct exogenous application of the substance to the postsynaptic membrane must reproduce the identical physiological and pharmacological response elicited by endogenous nerve stimulation.
• Inactivation Mechanism: Specific biological mechanisms (active reuptake, enzymatic degradation, or rapid diffusion) must terminate the chemical action within milliseconds to preserve synaptic temporal resolution.

2. Biosynthesis, vesicular packaging, and exocytosis

Neurotransmitter synthesis and release follow tightly coordinated cell-biological pathways [3]:

• Vesicular Loading: Small-molecule neurotransmitters are synthesized in presynaptic terminals by localized cytoplasmic enzymes. They are concentrated into clear synaptic vesicles (approximately 40 to 50 nm in diameter) against steep chemical gradients by vesicular transporters (such as VMAT for monoamines, VGAT for GABA and glycine, and VGLUT for glutamate). These transporters function as proton exchangers powered by vacuolar \(H^+\)-ATPase pumps.
• SNARE-Mediated Docking and Priming: Loaded vesicles dock at presynaptic active zones. Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins form a core four-helix bundle: synaptobrevin (VAMP) on the vesicle membrane pairs with syntaxin-1 and SNAP-25 on the plasma membrane. This complex primes the vesicle into a meta-stable state ready for instantaneous fusion.
• Calcium Triggering: An incoming action potential opens presynaptic voltage-gated calcium channels (\(Ca_V2.1\) and \(Ca_V2.2\)). Localized microdomains of elevated intracellular \(Ca^{2+}\) bind to synaptotagmin-1, the primary calcium sensor, triggering full SNARE bundle assembly and opening a fusion pore within sub-millisecond timescales [3].

3. Major chemical classes of neurotransmitters

Endogenous neurotransmitters fall into three principal structural families:

• Amino Acids: The primary fast-acting transmitters in the central nervous system.
  • Glutamate: The principal excitatory neurotransmitter in the vertebrate brain, mediating fast synaptic excitation.
  • GABA (\(\gamma\)-aminobutyric acid): The principal inhibitory neurotransmitter in the brain, preventing runaway cortical excitation.
  • Glycine: The primary inhibitory neurotransmitter in the spinal cord and brainstem.
• Biogenic Amines (Monoamines and Acetylcholine):
  • Acetylcholine: Functions at the neuromuscular junction, autonomic ganglia, and central cholinergic projection fields governing attention and arousal.
  • Catecholamines (Dopamine, Norepinephrine, Epinephrine): Synthesized from tyrosine via L-DOPA. Dopamine regulates motor control, motivation, executive gating, and reinforcement learning. Norepinephrine coordinates locus coeruleus vigilance and sympathetic arousal.
  • Indolamines (Serotonin / 5-HT): Synthesized from tryptophan; modulates mood, appetite, sleep-wake cycles, and sensory processing.
  • Histamine: Mediates central wakefulness and hypothalamic homeostatic control.
• Neuropeptides: Chains of 3 to 36 amino acids synthesized in the cell soma and packaged into dense-core vesicles (e.g., endorphins, substance P, neuropeptide Y, oxytocin, and vasopressin). Unlike classical small-molecule transmitters, neuropeptides require high-frequency burst firing for release, act at lower concentrations, and diffuse over wider distances to modulate neural circuits.

4. Postsynaptic actions: ionotropic versus metabotropic receptors

A neurotransmitter's physiological effect (excitatory, inhibitory, or modulatory) is entirely determined by the properties of the postsynaptic receptor to which it binds, rather than by the transmitter molecule itself:

• Ionotropic Receptors (Ligand-Gated Ion Channels): Multimeric protein complexes that form an intrinsic ion-conducting pore. Binding of neurotransmitter directly triggers conformational channel opening within microseconds. Examples include AMPA and NMDA receptors (cation-permeable, producing excitatory postsynaptic potentials) and \(GABA_A\) receptors (chloride-permeable, producing hyperpolarizing inhibitory postsynaptic potentials).
• Metabotropic Receptors (G-Protein-Coupled Receptors): Seven-transmembrane proteins that do not contain an ion pore. Ligand binding activates heterotrimeric G-proteins (\(G_s\), \(G_i/G_o\), \(G_q/G_{11}\)) that stimulate or inhibit intracellular second messenger cascades (such as cyclic AMP, inositol trisphosphate, and diacylglycerol) or open downstream G-protein-gated potassium channels. Metabotropic signaling operates over tens of milliseconds to minutes, modulating intrinsic membrane excitability and synaptic strength.

5. Signal termination and clearance kinetics

Following receptor interaction, the chemical signal must terminate rapidly to allow subsequent signals to register. Clearance occurs via dedicated pathways:

• Reuptake Transporters: High-affinity secondary active transporters (such as the SLC6 monoamine and GABA families, and SLC1 glutamate transporters) retrieve transmitters back into presynaptic terminals or surrounding astrocytes. Reuptake preserves metabolic efficiency by recycling synthesized neurotransmitters into new vesicle pools.
• Enzymatic Breakdown: Specific extracellular and intracellular enzymes cleave transmitters. Acetylcholinesterase hydrolyzes acetylcholine in the cleft. Monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) degrade cytoplasmic and extracellular catecholamines.
• Spillover and Astrocytic Buffering: Perisynaptic astrocytic processes tightly enwrap synapses, expressing high densities of glutamate transporters to prevent transmitter spillover to adjacent neighboring connections.